Achieving Value in Cancer Care

Video

This video explores the value proposition in cancer care, with practical considerations for reducing costs at both the hospital and physician level while maintaining optimal care for cancer patients.

With the rising costs of targeted agents, immunotherapies, and combination treatment strategies, creating value while maintaining optimal care for cancer patients is of critical importance.

In this video, Daniel R. Gomez, MD, of MD Anderson Cancer Center, discusses the value proposition in cancer care, with practical considerations for reducing costs at both the hospital and physician level without sacrificing high levels of care to patients.

Gomez gave a presentation on this topic at the 2017 Multidisciplinary Thoracic Cancers Symposium, held March 16–18 in San Francisco.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Future findings from a translational analysis of the OVATION-2 trial may corroborate prior clinical data with IMNN-001 in advanced ovarian cancer.
The dual high-affinity binding observed with ISB 2001 may avoid resistance mechanisms reported with other BCMA-targeted therapies.
The use of chemotherapy trended towards improved recurrence-free intervals in older patients with high-risk tumors as determined via the MammaPrint assay.
Use of a pharmacist-directed resource appears to improve provider confidence and adverse effect monitoring for patients undergoing infusion therapy.
Reshma L. Mahtani, DO, describes how updates from the DESTINY-Breast09, ASCENT-04, and VERITAC-2 trials may shift practices in the breast cancer field.